HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
4 hedge funds and large institutions have $377K invested in Hepion Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$278K |
2 |
ARTA
A.R.T. Advisors
New York
|
+$46K |
3 |
UBS Group
Zurich,
Switzerland
|
+$9K |
Top Sellers
1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$44K |
2 |
Renaissance Technologies
New York
|
-$43K |
3 |
VF
Virtu Financial
New York
|
-$39.1K |
4 |
Barclays
London,
United Kingdom
|
-$3K |
5 |
Morgan Stanley
New York
|
-$1K |